Wanling Xie

Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · Journal of Clinical Oncology · 2009 · 2.1K citations · Full text

Medicine, Oncology, Pharmacology +17

External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study

Daniel Y.C. Heng, Wanling Xie, Meredith M. Regan et al. · The Lancet Oncology · 2013 · 1K citations · Full text

Medicine, Biostatistics, Oncology +14

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma

Paul G. Richardson, Edie Weller, Sagar Lonial et al. · Blood · 2010 · 862 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Anti-CS1 humanized monoclonal antibody HuLuc63 inhibits myeloma cell adhesion and induces antibody-dependent cellular cytotoxicity in the bone marrow milieu

Yu‐Tzu Tai, Myles Dillon, Weihua Song et al. · Blood · 2007 · 473 citations · Full text

Medicine, Cell Biology, Oncology +14

Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer

Toshiro Migita, Stacey Ruiz, A Fornari et al. · JNCI Journal of the National Cancer Institute · 2009 · 389 citations · Full text

Life Sciences, Cancer Biology, Cell Biology +17